Skip to main content

Table 3 Percentage of cell populations in different stages of the cell cycle following exposure to different groups of nanoliposomes for 24 h

From: Preparation, characterization, and in-vitro cytotoxicity of nanoliposomes loaded with anti-tubercular drugs and TGF-β1 siRNA for improving spinal tuberculosis therapy

Treatment group

G1 phase

S phase

G2 phase

Untreated cells

51.73 ± 1.17

27.00 ± 3.44

21.26 ± 3.41

HRZ

55.13 ± 1.59

27.10 ± 5.93

17.83 ± 3.01

HRZ/siNC

54.06 ± 2.93

26.90 ± 4.38

17.90 ± 2.43

HRZ/siTGF-β1 (35 mg/ml)

46.95 ± 1.15

25.20 ± 3.22

26.84 ± 1.58

HRZ/siTGF-β1 (40 mg/ml)

41.07 ± 1.22

20.37 ± 2.34

38.54 ± 2.02**

  1. The results are presented as the average percentage of the cell population (%) ± standard deviation; P < 0.05*, *P < 0.01 vs. untreated cells